Several recent advances have been made in our understanding of the mechanis
ms which human natural killer cells recognize MHC class I molecules. Three
are of special relevance: the identification of a novel molecule (DAP12) wi
th a key role in the activation pathways; the observation that certain immu
noglobulin-like receptors for HLA class I molecules are also utilized by ot
her leucocyte lineages; and the definition of MHC class 1b proteins (i.e. H
LA-E and Qa-1b) as specific ligands for the phylogenetically conserved CD94
-NKG2 lectin-like receptors.